Evidence map›Paper›PMID 42505030›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Nanovesicles With Mechanically Induced Adjuvanticity for Robust Melanoma Vaccination Toward Tumor-Associated Macrophages.

Bangyue Luo, Liyan Qiu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bangyue LuoDepartment of Polymer Science and Engineering, Ministry of Educational (MOE) Key Laboratory of Macromolecular Synthesis and Functionalization, Zhejiang University, Hangzhou, China.ORCID https://orcid.org/0000-0003-1923-6892
Liyan QiuDepartment of Polymer Science and Engineering, Ministry of Educational (MOE) Key Laboratory of Macromolecular Synthesis and Functionalization, Zhejiang University, Hangzhou, China.ORCID https://orcid.org/0000-0002-5661-9422

Funding

National Natural Science Foundation of China 82273883
6 · The paper itself

Abstract

Tumor-associated macrophages (TAMs) are abundant in tumor microenvironment (TME) but fail to act as vaccine targets due to their inferior immune response. Here, a robust strategy was presented to develop potent cancer vaccines toward TAMs via a multi-functional adjuvant, breaking through the conventional vaccine design centered on dendritic cells (DCs). To address this issue, rigidity-tunable nanovesicles (P-P

Indexed as

Adjuvants, ImmunologicCancer VaccinesMelanomaMelanoma, ExperimentalNanoparticlesTumor-Associated MacrophagesAnimalsMiceMice, Inbred C57BLNanovaccinesTumor MicroenvironmentVaccinationAdjuvants, ImmunologicCancer VaccinesNanovaccinesimmunosuppression reversalmechanosensitive signaling pathwaymelanoma vaccinenanovesicle adjuvantstumor‐associated macrophages

Identifiers

PMID42505030
PMCPMC13403892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.